Stephanie Banakis

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Respiratory Tract

Chronic Rhinosinusitis

Immune Response

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Meenakshi Kar, Katherine E E Johnson, Abigail Vanderheiden, Elizabeth J Elrod, Katharine A Floyd, Elizabeth Geerling, E Taylor Taylor Stone, Eduardo Salinas, Stephanie Banakis, Wei Wang, Shruti Sathish, Swathi Shrihari, Meredith E Davis-Gardner, Jacob E Kohlmeier, Amelia K Pinto, Robyn Klein, Arash Grakoui, Elodie Ghedin, Mehul S Suthar
CD4 + and CD8 + T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment. Science advances 10 (34) (2024)
Meenakshi Kar, Katherine E E Johnson, Abigail Vanderheiden, Elizabeth J Elrod, Katharine A Floyd, Elizabeth Geerling, E Taylor Taylor Stone, Eduardo Salinas, Stephanie Banakis, Wei Wang, Shruti Sathish, Swathi Shrihari, Meredith E Davis-Gardner, Jacob E Kohlmeier, Amelia K Pinto, Robyn Klein, Arash Grakoui, Elodie Ghedin, Mehul S Suthar
CD4 + and CD8 + T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment. Science advances 10 (34) (2024)
Meenakshi Kar, Katherine E E Johnson, Abigail Vanderheiden, Elizabeth J Elrod, Katharine A Floyd, Elizabeth Geerling, E Taylor Taylor Stone, Eduardo Salinas, Stephanie Banakis, Wei Wang, Shruti Sathish, Swathi Shrihari, Meredith E Davis-Gardner, Jacob E Kohlmeier, Amelia K Pinto, Robyn Klein, Arash Grakoui, Elodie Ghedin, Mehul S Suthar
CD4 + and CD8 + T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment. Science advances 10 (34) (2024)
Meenakshi Kar, Katherine E E Johnson, Abigail Vanderheiden, Elizabeth J Elrod, Katharine A Floyd, Elizabeth Geerling, E Taylor Taylor Stone, Eduardo Salinas, Stephanie Banakis, Wei Wang, Shruti Sathish, Swathi Shrihari, Meredith E Davis-Gardner, Jacob E Kohlmeier, Amelia K Pinto, Robyn Klein, Arash Grakoui, Elodie Ghedin, Mehul S Suthar
CD4 + and CD8 + T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment. Science advances 10 (34) (2024)